Navigation Links
A protein in the brain paves way for Alzheimer's treatment

Alzheimer's is the most common form of dementia in Canada, affecting some 5% of people over the age of 65. Statistics show that one in four people// over the age of 85 suffer from the disease. According to the study conducted by Dr. Peter St George-Hyslop who is a researcher working on Alzheimer's disease at the University of Toronto it is said that a single chemical in the brain is the cause of the disease. The researchers have discovered a substance in the brain that can stop Alzheimer's disease and could lead to a treatment for the degenerative disorder.

By using this discovery a new drug can be developed against the disease. Medicines that will stop the progressing of the disease and also those that will help to prevent the occurrence of the disease would soon be discovered. TPM21 is the protein that blocks the neurotoxin Abeta. This is known as beta-amyloid peptide, which is responsible for the onset of Alzheimer's. TPM21 blocks Abeta production without causing any side effects. But St George-Hyslop also cautioned that it has yet to be tested in animals and that a drug to mimic its antitoxin effects is likely at least five years away.

The crucial point is now to discover a small molecule that resembles and functions in the same way as this protein. Abeta-blocking compound would likely be used in conjunction with other therapies, such as a promising new Alzheimer's vaccine. Alzheimer's drug therapy would also require ongoing doses over a patient's lifetime. Dr. B. Lynn Beattie, chair of the research policy committee for the Alzheimer Society of Canada, cautioned that the disease has an enormously complex biochemistry and that this newly revealed protein represents just one step in the development of the disease.


'"/>




Page: 1

Related medicine news :

1. Special proteins to fight TB identified
2. High-protein diets may pose health risks
3. Hidden influenza virus protein found
4. Special proteins to fight TB identified
5. Importance of soy protein in your diet
6. Unfavourable Lipid-Lipoprotein profiles in older adults has been linked to abdominal visceral fat
7. Stroke victims have new hope with activated protein C
8. Mental retardation linked to brain protein
9. HIV blocking protein in Monkey
10. Obese children may have abnormalities of lipoproteins
11. Artificially made protein to inhibit angiogenesis
Post Your Comments:
(Date:7/25/2008)...swire/ -- Klafter & Olsen LLP has filed a,class ac...roCare" or the,"Company") (Nasdaq: ARTC ) and cer...r the Western District of Texas on behalf of all p...ArthroCare from January 24, 2008,through July 18, ...nd all,persons or entities who purchased call opti...
(Date:7/25/2008)... antiretroviral therapy may be due to genetic fact... -- A new study challenges the long-held belief th...system,s ability to restore itself after HIV patie...therapy (HAART). , From 50 percent to 90 percen...h HCV. Intravenous drug use is the main cause of b...
(Date:7/25/2008)...e/ -- BeaconEquity.com announces the,availability ...estors can view all of the daily trading notes for...oday,s Trade Alerts include: DUSA Pharmaceuticals ... Inc. (Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA...(Nasdaq: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )....
(Date:7/25/2008)...n Significant Improvements in Members, Health, AT...leader in health,care quality management solutions...t has entered into a long-term agreement with Well...boration on Quality(SM) Incent and,Reward Best Pra...k and,primary care clinicians to promote improved ...
Breaking Medicine News(10 mins):Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 2Health News:Klafter & Olsen LLP Announces That It Has Filed a Class Action Lawsuit Against ArthroCare Corporation on Behalf of Common Stock Holders and Certain Traders in ArthroCare Options 3Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3
...he use of biomarkers to predict the risk of cardio...y population has found that, even though some meas...ar events, their usefulness for predicting risk in... from the Framingham Heart Study appears in the De...
...co-authored by Children's Hospital Oakland Researc...eil, Ph.D., is the first to show that partial copi...nto specific three dimensional shapes when it comb...iscovery is incredibly important to researchers wh...
... journal of the American Neurological Association,...nd that VENs were devastated in FTD//. Von Econom...hat seem to have evolved in a select group of soci..., and, as reported last month, whales. Across spec...
...g to not that slothfulness is on the rise among te...K was an eye opener//. The study revealed that ump...to put in efforts for constructive physical activi...vision or tinkering with computer games. This tren...
Other Medicine News:Health News:Biomarkers Ability to Predict Heart Disease and Stroke is Limited 2Health News:Biomarkers Ability to Predict Heart Disease and Stroke is Limited 3Health News:A Study Finds VENs Devastated in FTD 2
(Date:7/23/2008)... WASHINGTON, July 23 /PRNewswire-USNewswire/ ...nt of Justice:, Chairman Conyers, Ranking Member ... the opportunity to testify today., Since I appea... have,become even better acquainted with the talen...artment and with the work they do, and I have come...
(Date:7/23/2008)... SEATTLE, July 23 /- D...ed that it expects the Independent Data,Monitoring...terim analysis,of overall survival relating to the...ate AdenoCarcinoma Treatment, also known as D9902B...OVENGE is the Company,s investigational,active cel...
(Date:7/22/2008)... MINNEAPOLIS, July 22 /- Nonin M...oring solutions for more than 20 years, has entere... technology to measure,regional oxygen saturation....gy is the continuous monitoring of the regional bl..., Early testing data and outcomes from an ongoing...
(Date:7/22/2008)... - State-of-the-Art PET Study Confirms Tyrima Ex... Properties - - Results Support Initiat...GLE PARK, N.C., July 22 /- CeNeRx Bio...and commercializing innovative,treatments for dise...d,plans to advance its lead candidate Tyrima(TM) i...
Breaking Medicine Technology:Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 2Prepared Remarks of Attorney General Michael B. Mukasey Before the House Judiciary Committee 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 2Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 3Dendreon Expects Interim Data Analysis for Phase 3 PROVENGE IMPACT Trial in October 4Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 2CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 3CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study 4Bottom trawling impacts clearly visible from space 2221 1Bottom trawling impacts clearly visible from space 2221 2Bottom trawling impacts clearly visible from space 2221 3Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 1Dr Welsh Self Test Diagnoses Glaucoma the Leading Cause of Preventable Blindness 12056 2DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 1DentaBurst 28TM 29 Freshening Teeth Cleaners Launches Outshine Everyone Video Contest 12052 2Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 1Moving beyond tamoxifen 3A Drug discovery and the future of selective hormone receptor modulators 12049 2
...ontributing Editor , ,Appendicitis is a co... of individuals sometime in their lives. The cond...ntestine at the proximal colon, becomes obstructed...ensues, which can rapidly evolve to perforation an...y elevated for children and those over 50, rises a...
... Human papillomaviruses (HPVs) are small, closed c...sified by nucleic acid sequence homology rather th...t prevalent sexually transmitted pathogens. Of th...mited number of high and intermediate risk types d...rldwide, HPV has been associated with 99.7% of squ...
Other Medicine Technology:Appendicitis: Evolving Tools to Diagnose a Classic Disease 2Appendicitis: Evolving Tools to Diagnose a Classic Disease 3Testing for Human Papillomavirus 2Testing for Human Papillomavirus 3
Topcon offers an all-metal Trial Frame that is durably constructed, yet lightweight. It features a practical screw-thread design that extends the life of the trial frame by allowing for easy replacem
Inquire
...s the newest generation of electronic refractors. ...ws you to control the refractor from a keypad that...so controls the CP-670 Automatic Chart Projector. ...button, all the lenses are moved for you, taking y...
Uniquely designed, the wheelchair table has dual purposes. Not only does it add a modern look to any office, it is also a heavy-duty table that will support multiple instruments, and/or easily accomm
Medicine Products: